We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

146 hedge funds and large institutions have $89.2M invested in ImmunityBio in 2023 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 26

5% more funds holding

Funds holding: 139 → 146 (+7)

4% more call options, than puts

Call options by funds: $1.32M | Put options by funds: $1.27M

5% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 42

1.61% less ownership

Funds ownership: 12.21% → 10.6% (-1.6%)

65% less capital invested

Capital invested by funds: $256M → $89.2M (-$167M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
146
Holders Change
+7
Holders Change %
+5.04%
% of All Funds
2.33%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
33
Increased
40
Reduced
42
Closed
26
Calls
$1.32M
Puts
$1.27M
Net Calls
+$56K
Net Calls Change
+$1.12M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$18M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$4.9M
3
TCM
Tang Capital Management
California
+$3.41M
4
Millennium Management
Millennium Management
New York
+$1.62M
5
Squarepoint
Squarepoint
New York
+$1.5M

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$38.6M
2
State Street
State Street
Massachusetts
-$12.7M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$2.56M
4
Goldman Sachs
Goldman Sachs
New York
-$2.48M
5
Rafferty Asset Management
Rafferty Asset Management
New York
-$2.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
IFAM
126
Institutional & Family Asset Management
Colorado
$2.37K – – –
US Bancorp
127
US Bancorp
Minnesota
$2.23K +$271 +87 +8%
Northwestern Mutual Wealth Management
128
Northwestern Mutual Wealth Management
Wisconsin
$1.82K – – –
ASN
129
Advisory Services Network
Georgia
$1.46K -$7.46K -2,400 -75%
AF
130
Advisornet Financial
Minnesota
$1.36K -$12 -4 -0.5%
AAP
131
Arax Advisory Partners
Colorado
$1.09K – – –
CG
132
Cutler Group
California
$1K -$13.7K -4,394 -87%
BFEC
133
Benjamin F. Edwards & Company
Missouri
$1K – – –
ATC
134
Adirondack Trust Company
New York
$814 – – –
CTA
135
Colonial Trust Advisors
South Carolina
$774 – – –
SWM
136
Spire Wealth Management
Virginia
$768 – – –
QC
137
Quent Capital
New York
$732 +$277 +89 +28%
PA
138
PSI Advisors
Florida
$637 – – –
NA
139
NewEdge Advisors
Louisiana
$455 – – –
BWM
140
BerganKDV Wealth Management
Minnesota
$210 – – –
CBT
141
Central Bank & Trust
Kentucky
$144 – – –
DFCM
142
Dark Forest Capital Management
Puerto Rico
$46 +$78 +25 New
SC
143
Schubert & Co
Texas
$10 -$19 -6 -55%
SIC
144
SJS Investment Consulting
Ohio
$6 -$3 -1 -25%
DI
145
Disciplined Investments
Oklahoma
$2 -$12 -4 -80%
CH
146
CVI Holdings
Delaware
– -$38.6M -7,609,166 Closed
Rafferty Asset Management
147
Rafferty Asset Management
New York
– -$2.39M -471,523 Closed
PI
148
Putnam Investments
Massachusetts
– -$872K -171,939 Closed
CAM
149
ClariVest Asset Management
California
– -$454K -89,642 Closed
Ameriprise
150
Ameriprise
Minnesota
– -$345K -67,995 Closed
3 4 5
6
7

IBRX Hedge Fund Activity: Q1 2023 in Review

146 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q1 2023, worth a combined $89.2M — down 65% from $256M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new IBRX positions and 26 closed out — a net gain of 7 holders — while 40 added to existing stakes and 42 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $18M. The largest seller was CVI Holdings, exiting entirely with an estimated $38.6M sold.

  • 146 institutional investors held ImmunityBio (IBRX) as of Q1 2023, up from 139 in Q4 2022.
  • Funds reported $89.2M of ImmunityBio stock for Q1 2023, down 65% quarter-over-quarter.
  • 33 funds opened new ImmunityBio positions in Q1 2023 and 26 closed out, a net change of +7 holders.
  • The largest ImmunityBio buyer in Q1 2023 was Armistice Capital, an estimated $18M added.
  • The largest ImmunityBio seller in Q1 2023 was CVI Holdings, an estimated $38.6M sold.

Based on aggregated 13F filings for Q1 2023.